查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1755898

2032 年行動心電圖設備市場預測：按產品類型、連接性、分銷管道、技術、應用、最終用戶和地區進行的全球分析

Mobile ECG Devices Market Forecasts to 2032 - Global Analysis By Product Type, Connectivity, Distribution Channel, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球行動心電圖設備市場預計在 2025 年達到 46 億美元，到 2032 年將達到 103 億美元，預測期內的複合年成長率為 12.2%。

行動心電圖設備是可攜式心電圖監控系統，旨在即時追蹤心臟活動。這些緊湊型設備採用先進的感測器檢測電訊號，無需就診即可進行遠端心臟評估。它們支持早期發現心律不整和心律不齊，從而提升患者便利性和預防性醫療保健。行動心電圖設備整合無線技術，可將資料無縫傳輸給醫療專業人員，以便及時分析。

根據心律學會發表的報導，心房顫動是最常見的心律不整之一，影響全球約4,000萬人，其中包括美國約600萬人。

全球心血管疾病（CVD）盛行率不斷上升

由於人口老化和生活方式因素，心臟相關疾病日益普遍，對高效即時監測解決方案的需求也日益成長。行動心電圖設備可讓使用者遠端追蹤心臟活動，從而實現主動的醫療保健管理，減少就診次數和緊急干預。這些設備在早期發現和預防方面發揮關鍵作用，有助於及時進行醫療干預，並改善患者預後。

資料隱私和安全問題

由於這些設備收集敏感的健康資訊，確保安全傳輸和儲存仍然是一項關鍵挑戰。網路安全風險（包括未授權存取和資料外洩）威脅著病患的隱私。遵守嚴格的監管要求增加了實施的複雜性，並需要強大的加密和身份驗證通訊協定，從而阻礙了市場的成長。

整合人工智慧和機器學習

人工智慧主導的演算法能夠即時識別細微的心律不整，從而提高診斷準確性，減少假陽性並改善臨床決策。預測分析能夠進行早期風險評估，並幫助醫療專業人員根據持續監測數據制定個人化治療方案。人工智慧心電圖解決方案能夠簡化工作流程，提高效率，最佳化遠距病患管理，進而降低醫療成本。

非專家對數據的誤解

非專業使用者誤讀資料的風險，對有效使用行動心電圖設備構成了重大挑戰。雖然此類設備能夠增強自我監測能力，但錯誤的讀數和不準確的分析可能會導致不必要的擔憂和症狀的忽視。未經醫學訓練的使用者可能難以正確解讀結果，從而延誤重要治療或引起過度焦慮，阻礙市場成長。

COVID-19的影響

疫情加速了行動心電圖設備的普及，因為醫療保健系統優先考慮對患者的遠端監控，以減少就診次數並最大程度地降低暴露風險。遠端醫療和數位健康平台的興起增加了對穿戴式和可攜式心電圖解決方案的需求。雖然供應鏈中斷最初影響了生產，但由於對數位醫療基礎設施的投資增加，市場已經反彈。

手持式心電圖設備市場預計將在預測期內實現最大幅度成長

手持式心電圖設備憑藉其便攜性和易用性，預計在預測期內將佔據最大的市場佔有率。這些小型設備能夠快速評估心臟狀況，因此在臨床和個人應用中都具有很高的價值。與智慧型手機和雲端基礎系統的整合增強了可存取性和遠端資料傳輸。手持式心電圖設備在醫療保健專業人士和消費者中的廣泛應用凸顯了其在預防性醫療保健中的重要性，從而增加了對高效且方便用戶使用的心臟監測解決方案的需求。

預計心律不整監測部分在預測期內將達到最高的複合年成長率。

由於人們越來越重視早期檢測和持續的心臟健康追蹤，預計心律不整監測領域將在預測期內實現最高成長率。具有主導的心律不整檢測功能的行動心電圖設備將提高診斷準確性，並支援及時的醫療介入。感測器技術和穿戴式裝置整合的進步將有助於實現無縫監測，使用戶能夠有效地追蹤心率。

比最大的地區

在預測期內，亞太地區預計將佔據最大的市場佔有率，這得益於醫療保健意識的提升、數位健康舉措的不斷擴展以及人口老齡化。政府對醫療技術的投入以及消費者對穿戴式心電圖設備的日益普及正在推動市場的發展。快速的都市化和心血管疾病的流行進一步推動了該地區對行動心電圖解決方案的需求。

複合年成長率最高的地區

在預測期內，北美預計將呈現最高的複合年成長率，這得益於技術進步、人工智慧主導的診斷技術以及強大的醫療基礎設施。該地區對遠端醫療和遠端患者監護的關注加速了行動心電圖設備的普及，因為它們在預防性心臟護理中發揮關鍵作用。憑藉其支持性的法律規範和對數位醫療創新的大量投資，上述因素使北美成為心電圖設備開發和部署的主要樞紐。

免費客製化服務

訂閱此報告的客戶可享有以下免費自訂選項之一：

  • 公司簡介
    • 對其他市場參與企業（最多 3 家公司）進行全面分析
    • 主要企業的SWOT分析（最多3家公司）
  • 地理細分
    • 根據客戶興趣對主要國家進行市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 透過產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 研究範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究材料
    • 主要研究資料
    • 二手研究資料
    • 先決條件

第3章市場走勢分析

  • 介紹
  • 驅動程式
  • 限制因素
  • 機會
  • 威脅
  • 產品分析
  • 技術分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買家的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

第5章全球行動心電圖設備市場（依產品類型）

  • 介紹
  • 手持式心電圖設備
  • 穿戴式心電圖設備
  • 筆式心電圖儀
  • 其他

6. 全球行動心電圖設備市場-按連線類型

  • 介紹
  • Bluetooth
  • Wi-Fi
  • USB
  • 行動電話網路

7. 全球行動心電圖設備市場（依通路）

  • 介紹
  • 線上平台
  • 藥局
  • 醫療設備經銷商
  • 醫院/診所供應鏈

8. 全球行動心電圖設備市場（按技術）

  • 介紹
  • 單導聯心電圖
  • 三導聯心電圖
  • 6導聯心電圖
  • 12導聯心電圖

9. 全球行動心電圖設備市場（依應用）

  • 介紹
  • 心律不整監測
  • 心房顫動檢測
  • 心率監測
  • 心臟缺血監測
  • 其他

第 10 章全球行動心電圖設備市場（依最終用戶）

  • 介紹
  • 醫院和診所
  • 居家照護
  • 門診手術中心
  • 個人使用者/患者
  • 診斷中心
  • 其他

第 11 章全球行動心電圖設備市場（按地區）

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第12章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第13章 公司概況

  • Apple Inc.
  • AliveCor Inc.
  • Bittium Corporation
  • CardioComm Solutions Inc.
  • GE Healthcare
  • Hillrom Holdings Inc.
  • iRhythm Technologies Inc.
  • Medtronic plc
  • Nihon Kohden Corporation
  • Omron Healthcare Inc.
  • Philips Healthcare
  • Qardio Inc.
  • Schiller AG
  • VitalConnect Inc.
  • Beurer GmbH
  • BPL Medical Technologies
  • Edan Instruments Inc.
  • Withings SA
Product Code: SMRC29792

According to Stratistics MRC, the Global Mobile ECG Devices Market is accounted for $4.6 billion in 2025 and is expected to reach $10.3 billion by 2032 growing at a CAGR of 12.2% during the forecast period. Mobile ECG devices are portable electrocardiogram monitoring systems designed to track heart activity in real time. These compact devices use advanced sensors to detect electrical signals, enabling remote cardiac assessments without clinical visits. They support early detection of arrhythmias and heart irregularities, enhancing patient convenience and preventive healthcare. Integrated with wireless technology, mobile ECGs offer seamless data transmission to medical professionals for timely analysis.

According to article published by the Heart Rhythm Society, atrial fibrillation is one of the most common types of cardiac arrhythmia and affects around 40 million people globally. In addition, the condition affects approximately 6 million people in the U.S.

Market Dynamics:

Driver:

Increasing global incidence of cardiovascular diseases (CVDs)

Heart-related conditions becoming more prevalent due to aging populations and lifestyle factors, the need for efficient, real-time monitoring solutions is increasing. Mobile ECG devices enable proactive healthcare management by allowing users to track heart activity remotely, reducing hospital visits and emergency interventions. These devices play a vital role in early detection and prevention, facilitating timely medical intervention and improving patient outcomes.

Restraint:

Data privacy and security concerns

As these devices collect sensitive health information, ensuring secure transmission and storage remains a critical issue. Cybersecurity risks, including unauthorized access and data breaches, pose threats to patient confidentiality. Compliance with stringent regulatory requirements adds complexity to implementation, requiring robust encryption and authentication protocols hampers the market growth.

Opportunity:

Integration with AI and machine learning

AI-driven algorithms enhance diagnostic accuracy by identifying subtle cardiac irregularities in real-time, reducing false readings and improving clinical decision-making. Predictive analytics enable early risk assessment, helping healthcare professionals tailor personalized treatment plans based on continuous monitoring data. AI-powered ECG solutions streamline workflow efficiency, optimizing remote patient management and reducing healthcare costs.

Threat:

Misinterpretation of data by non-professionals

The risk of data misinterpretation by non-professional users poses a significant challenge to the effective use of mobile ECG devices. While these devices empower individuals with self-monitoring capabilities, improper readings or inaccurate analysis may lead to unnecessary concern or overlooked symptoms. Users without medical training may struggle to interpret results correctly, potentially delaying crucial treatment or causing unwarranted anxiety impeding the market growth.

Covid-19 Impact:

The pandemic accelerated the adoption of mobile ECG devices as healthcare systems prioritized remote patient monitoring to reduce hospital visits and minimize exposure risks. Telemedicine and digital health platforms became more prevalent, driving demand for wearable and portable ECG solutions. Supply chain disruptions initially affected production, but increased investment in digital healthcare infrastructure led to market recovery.

The handheld ECG devices segment is expected to be the largest during the forecast period

The handheld ECG devices segment is expected to account for the largest market share during the forecast period due to their portability and ease of use. These compact devices provide quick cardiac assessments, making them highly valuable for both clinical and personal applications. Their integration with smartphones and cloud-based systems enhances accessibility and remote data transmission. Widespread adoption among healthcare professionals and consumers underscores their importance in preventive care, driving demand for efficient and user-friendly cardiac monitoring solutions.

The arrhythmia monitoring segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the arrhythmia monitoring segment is predicted to witness the highest growth rate fueled by the growing emphasis on early detection and continuous heart health tracking. Mobile ECG devices equipped with AI-driven arrhythmia detection capabilities enhance diagnostic accuracy, supporting timely medical intervention. Advancements in sensor technology and wearable integrations contribute to seamless monitoring, allowing users to track heart rhythm irregularities efficiently.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share driven by increasing healthcare awareness, expanding digital health initiatives, and a growing aging population. Government investments in medical technology and rising consumer adoption of wearable ECG devices contribute to market leadership. Rapid urbanization and the prevalence of cardiovascular conditions further support regional demand for mobile ECG solutions.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR propelled by technological advancements, AI-driven diagnostics, and robust healthcare infrastructure. The region's strong focus on telemedicine and remote patient monitoring accelerates adoption, as mobile ECG devices play a vital role in preventive cardiac care. Supportive regulatory frameworks and significant investments in digital healthcare innovations reinforce This aforementioned factors position North America as a leading hub for ECG device development and deployment.

Key players in the market

Some of the key players in Mobile ECG Devices Market include Apple Inc., AliveCor Inc., Bittium Corporation, CardioComm Solutions Inc., GE Healthcare, Hillrom Holdings Inc., iRhythm Technologies Inc., Medtronic plc, Nihon Kohden Corporation, Omron Healthcare Inc., Philips Healthcare, Qardio Inc., Schiller AG, VitalConnect Inc., Beurer GmbH, BPL Medical Technologies, Edan Instruments Inc., and Withings SA.

Key Developments:

In May 2025, AliveCor introduced the KardiaMobile 6L Max and KardiaAlert, its most advanced personal ECG system yet, bringing enhanced AI-powered 6-lead monitoring for consumers and clinicians. This launch strengthens its position in digital cardiac care by offering real-time alerts and enhanced diagnostic reach

In May 2025, iRhythm rolled out its Zio long-term ECG recording and analysis service in Japan, expanding its AI-powered arrhythmia detection platform into Asian markets. This launch marks a major international expansion for its digital health offerings.

In May 2025, AliveCor teamed up with AI-health startup Anumana to integrate advanced FDA-cleared LEF detection algorithms into Kardia devices for early cardiac disease screening. This collaboration enhances clinical intelligence and paves the way for next-generation AI-enabled ECG diagnostics.

Product Types Covered:

  • Handheld ECG Devices
  • Wearable ECG Devices
  • Pen-type ECG Devices
  • Other Product Types

Connectivities Covered:

  • Bluetooth
  • Wi-Fi
  • USB
  • Cellular Network

Distribution Channels Covered:

  • Online Platforms
  • Pharmacies
  • Medical Device Stores
  • Hospital/Clinic Supply Chains

Technologies Covered:

  • Single-Lead ECG
  • 3-Lead ECG
  • 6-Lead ECG
  • 12-Lead ECG

Applications Covered:

  • Arrhythmia Monitoring
  • Atrial Fibrillation Detection
  • Heart Rate Monitoring
  • Cardiac Ischemia Monitoring
  • Other Applications

End Users Covered:

  • Hospitals & Clinics
  • Home Care Settings
  • Ambulatory Surgical Centers
  • Individual Users/Patients
  • Diagnostic Centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Mobile ECG Devices Market, By Product Type

  • 5.1 Introduction
  • 5.2 Handheld ECG Devices
  • 5.3 Wearable ECG Devices
  • 5.4 Pen-type ECG Devices
  • 5.5 Other Product Types

6 Global Mobile ECG Devices Market, By Connectivity

  • 6.1 Introduction
  • 6.2 Bluetooth
  • 6.3 Wi-Fi
  • 6.4 USB
  • 6.5 Cellular Network

7 Global Mobile ECG Devices Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Online Platforms
  • 7.3 Pharmacies
  • 7.4 Medical Device Stores
  • 7.5 Hospital/Clinic Supply Chains

8 Global Mobile ECG Devices Market, By Technology

  • 8.1 Introduction
  • 8.2 Single-Lead ECG
  • 8.3 3-Lead ECG
  • 8.4 6-Lead ECG
  • 8.5 12-Lead ECG

9 Global Mobile ECG Devices Market, By Application

  • 9.1 Introduction
  • 9.2 Arrhythmia Monitoring
  • 9.3 Atrial Fibrillation Detection
  • 9.4 Heart Rate Monitoring
  • 9.5 Cardiac Ischemia Monitoring
  • 9.6 Other Applications

10 Global Mobile ECG Devices Market, By End User

  • 10.1 Introduction
  • 10.2 Hospitals & Clinics
  • 10.3 Home Care Settings
  • 10.4 Ambulatory Surgical Centers
  • 10.5 Individual Users/Patients
  • 10.6 Diagnostic Centers
  • 10.7 Other End Users

11 Global Mobile ECG Devices Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Apple Inc.
  • 13.2 AliveCor Inc.
  • 13.3 Bittium Corporation
  • 13.4 CardioComm Solutions Inc.
  • 13.5 GE Healthcare
  • 13.6 Hillrom Holdings Inc.
  • 13.7 iRhythm Technologies Inc.
  • 13.8 Medtronic plc
  • 13.9 Nihon Kohden Corporation
  • 13.10 Omron Healthcare Inc.
  • 13.11 Philips Healthcare
  • 13.12 Qardio Inc.
  • 13.13 Schiller AG
  • 13.14 VitalConnect Inc.
  • 13.15 Beurer GmbH
  • 13.16 BPL Medical Technologies
  • 13.17 Edan Instruments Inc.
  • 13.18 Withings SA

List of Tables

  • Table 1 Global Mobile ECG Devices Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Mobile ECG Devices Market Outlook, By Product Type (2024-2032) ($MN)
  • Table 3 Global Mobile ECG Devices Market Outlook, By Handheld ECG Devices (2024-2032) ($MN)
  • Table 4 Global Mobile ECG Devices Market Outlook, By Wearable ECG Devices (2024-2032) ($MN)
  • Table 5 Global Mobile ECG Devices Market Outlook, By Pen-type ECG Devices (2024-2032) ($MN)
  • Table 6 Global Mobile ECG Devices Market Outlook, By Other Product Types (2024-2032) ($MN)
  • Table 7 Global Mobile ECG Devices Market Outlook, By Connectivity (2024-2032) ($MN)
  • Table 8 Global Mobile ECG Devices Market Outlook, By Bluetooth (2024-2032) ($MN)
  • Table 9 Global Mobile ECG Devices Market Outlook, By Wi-Fi (2024-2032) ($MN)
  • Table 10 Global Mobile ECG Devices Market Outlook, By USB (2024-2032) ($MN)
  • Table 11 Global Mobile ECG Devices Market Outlook, By Cellular Network (2024-2032) ($MN)
  • Table 12 Global Mobile ECG Devices Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 13 Global Mobile ECG Devices Market Outlook, By Online Platforms (2024-2032) ($MN)
  • Table 14 Global Mobile ECG Devices Market Outlook, By Pharmacies (2024-2032) ($MN)
  • Table 15 Global Mobile ECG Devices Market Outlook, By Medical Device Stores (2024-2032) ($MN)
  • Table 16 Global Mobile ECG Devices Market Outlook, By Hospital/Clinic Supply Chains (2024-2032) ($MN)
  • Table 17 Global Mobile ECG Devices Market Outlook, By Technology (2024-2032) ($MN)
  • Table 18 Global Mobile ECG Devices Market Outlook, By Single-Lead ECG (2024-2032) ($MN)
  • Table 19 Global Mobile ECG Devices Market Outlook, By 3-Lead ECG (2024-2032) ($MN)
  • Table 20 Global Mobile ECG Devices Market Outlook, By 6-Lead ECG (2024-2032) ($MN)
  • Table 21 Global Mobile ECG Devices Market Outlook, By 12-Lead ECG (2024-2032) ($MN)
  • Table 22 Global Mobile ECG Devices Market Outlook, By Application (2024-2032) ($MN)
  • Table 23 Global Mobile ECG Devices Market Outlook, By Arrhythmia Monitoring (2024-2032) ($MN)
  • Table 24 Global Mobile ECG Devices Market Outlook, By Atrial Fibrillation Detection (2024-2032) ($MN)
  • Table 25 Global Mobile ECG Devices Market Outlook, By Heart Rate Monitoring (2024-2032) ($MN)
  • Table 26 Global Mobile ECG Devices Market Outlook, By Cardiac Ischemia Monitoring (2024-2032) ($MN)
  • Table 27 Global Mobile ECG Devices Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 28 Global Mobile ECG Devices Market Outlook, By End User (2024-2032) ($MN)
  • Table 29 Global Mobile ECG Devices Market Outlook, By Hospitals & Clinics (2024-2032) ($MN)
  • Table 30 Global Mobile ECG Devices Market Outlook, By Home Care Settings (2024-2032) ($MN)
  • Table 31 Global Mobile ECG Devices Market Outlook, By Ambulatory Surgical Centers (2024-2032) ($MN)
  • Table 32 Global Mobile ECG Devices Market Outlook, By Individual Users/Patients (2024-2032) ($MN)
  • Table 33 Global Mobile ECG Devices Market Outlook, By Diagnostic Centers (2024-2032) ($MN)
  • Table 34 Global Mobile ECG Devices Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.